RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 PT May Be Safer than PF Chemoradiotherapy for LAEC
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 31
SP 15
OP 16
DO 10.1177/155989771431014
UL http://mdc.sagepub.com/content/14/31/15.abstract
AB Current neoadjuvant chemoradiation therapy (nCRT) for locally advanced esophageal cancer (LAEC) consists of radiation with platinum/5-FU (PF) chemotherapy. However, carboplatin/paclitaxel (PT) may be a favorable chemotherapy combination with preoperative radiation. The study discussed in this article investigated whether nCRT with PT would result in better perioperative outcomes.